Recent advances in transcatheter aortic valve replacement for high-risk patients

Expert Review of Cardiovascular Therapy

Volumn 13, Issue 11, 2015, Pages 1237-1249

  Mangieri, Antonio ^a   Regazzoli, Damiano ^a   Ruparelia, Neil ^a,b,c   Colombo, Antonio ^a,c   Latib, Azeem ^a,c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c EMO GVM CENTRO CUORE COLUMBUS   (Italy)

Author keywords

aortic stenosis; TAVR; Transcatheter aortic valve replacement

Indexed keywords

ACURATE VALVE; AORTA VALVE REGURGITATION; ATRIOVENTRICULAR BLOCK; BICUSPID AORTIC VALVE; CENTERA VALVE; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; COREVALVE PROSTHESIS; DIRECT FLOW MEDICAL VALVE; ENGAGER; FOLLOW UP; HEART LEFT VENTRICLE OUTFLOW TRACT; HIGH RISK PATIENT; HUMAN; JENA VALVE; LOTUS VALVE; LOW RISK PATIENT; MEDICAL SOCIETY; MORTALITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; PARAVALVULAR LEAK; PERCUTANEOUS AORTIC VALVE; REVIEW; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VASCULAR DISEASE; AORTA VALVE; AORTIC VALVE STENOSIS; HEART VALVE PROSTHESIS; PROCEDURES; PROGNOSIS; RISK;

AORTIC VALVE; AORTIC VALVE STENOSIS; HEART VALVE PROSTHESIS; HUMANS; PROGNOSIS; RISK; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 84947488131     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2015.1093935     Document Type: Review

References (77)

1. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368I: 1005-11
2. Brown JM, OBrien SM, Wu C, et al. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg 2009; 137I: 82-90
3. Sedrakyan A, Vaccarino V, Paltiel AD, et al. Age does not limit quality of life improvement in cardiac valve surgery. J Am Coll Cardiol 2003; 42I: 1208-14
4. Avery GJ II, Ley SJ, Hill JD, et al. Cardiac surgery in the octogenarian: evaluation of risk, cost, and outcome. Ann Thorac Surg 2001; 71I: 591-6
5. Sharma UC, Barenbrug P, Pokharel S, et al. Systematic review of the outcome of aortic valve replacement in patients with aortic stenosis. Ann Thorac Sur 2004; 78I: 90-5
6. Nowicki ER, Birkmeyer NJ, Weintraub RW, et al. Multivariable prediction of in-hospital mortality associated with aortic and mitral valve surgery in Northern New England. Ann Thorac Surg 2004; 77I: 1966-77
7. Speziale G, Nasso G, Barattoni MC, et al. Short-term and long-term results of cardiac surgery in elderly and very elderly patients. J Thorac Cardiovasc Surg 2011; 141I: 725-31. 31 e1
8. Mylotte D, Osnabrugge RL, Windecker S, et al. Transcatheter aortic valve replacement in Europe: adoption trends and factors influencing device utilization. J Am Coll Cardiol 2013; 62I: 210-19
9. Osnabrugge RL, Mylotte D, Head SJ, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol 2013; 62I: 1002-12
10. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106I: 3006-8
11. Abdel-Wahab M, Zahn R, Gerckens U, et al. Predictors of 1-year mortality in patients with aortic regurgitation after transcatheter aortic valve implantation: an analysis from the multicentre German TAVI registry. Heart 2014; 100I: 1250-6
12. Gilard M, Eltchaninoff H, Iung B, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012; 366I: 1705-15
13. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic bioprosthesis european outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010; 122I: 62-9
14. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364I: 2187-98
15. Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012; 366I: 1686-95
16. Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015
17. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363I: 1597-607
18. Makkar RR, Fontana GP, Jilaihawi H, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012; 366I: 1696-704
19. Kapadia SR, Tuzcu EM, Makkar RR, et al. Long-term outcomes of inoperable patients with aortic stenosis randomly assigned to transcatheter aortic valve replacement or standard therapy. Circulation 2014; 130I: 1483-92
20. Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 2014; 370I: 1790-8
21. Reardon MJ, Adams DH, Kleiman NS, et al. 2-year outcomes in patients undergoing surgical or self-expanding transcatheter aortic valve replacement. J Am Coll Cardiol 2015
22. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 2012; 42I: S1-44
23. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63I: 2438-88
24. Roques F, Nashef SA, Michel P, et al. Risk factors for early mortality after valve surgery in Europe in the 1990s: lessons from the EuroSCORE pilot program. J Heart Valve Dis 2001; 10I: 572-7; discussion 77-8
25. Ferguson TB Jr, Dziuban SW Jr, Edwards FH, et al. The STS national database: current changes and challenges for the new millennium. committee to establish a national database in cardiothoracic surgery, the society of thoracic surgeons. Ann Thorac Surg 2000; 69I: 680-91
26. Piazza N, Wenaweser P, van Gameren M, et al. Relationship between the logistic EuroSCORE and the Society of Thoracic Surgeons Predicted Risk of Mortality score in patients implanted with the CoreValve ReValving system- Bern-Rotterdam Study. Am Heart J 2010; 159I: 323-9
27. Smith LA, Dworakowski R, Bhan A, et al. Real-time three-dimensional transesophageal echocardiography adds value to transcatheter aortic valve implantation. J Am Soc Echocardiograp 2013; 26I: 359-69
28. Ng AC, Delgado V, van der Kley F, et al. Comparison of aortic root dimensions and geometries before and after transcatheter aortic valve implantation by 2- and 3-dimensional transesophageal echocardiography and multislice computed tomography. Circulation. Cardiovascular imaging 2010; 3I: 94-102
29. Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011; 123I: 299-308
30. Kodali S. Clinical and echocardiographic outcomes at 30 Days with the SAPIEN 3 TAVR system in inoperable, high-risk and intermediate-risk AS Patients. Am Coll Cardiol 2015
31. Petronio AS, De Carlo M, Bedogni F, et al. Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system. Circulation. Cardiovascular interventions 2010; 3I: 359-66
32. Piazza N, Martucci G, Lachapelle K, et al. First-in-human experience with the Medtronic CoreValve Evolut R. EuroIntervention 2014; 9I: 1260-3
33. Meredith IT. Early results from the Corevalve Evolut R CE Study. The Annual Meeting of the American College of Cardiology. March 14, 2015
34. Schofer J, Colombo A, Klugmann S, et al. Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve. J Am Coll Cardiol 2014; 63I: 763-8
35. Buellesfeld L, Gerckens U, Grube E. Percutaneous implantation of the first repositionable aortic valve prosthesis in a patient with severe aortic stenosis. Catheter Cardiovasc Interv 2008; 71I: 579-84
36. Meredith Am IT, Walters DL, Dumonteil N, et al. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study. J Am Coll Cardiol 2014; 64I: 1339-48
37. Binder RK, Schafer U, Kuck KH, et al. Transcatheter aortic valve replacement with a new self-expanding transcatheter heart valve and motorized delivery system. JACC Cardiovasc Interv 2013; 6I: 301-7
38. Treede H, Rastan A, Ferrari M, et al. JenaValve. EuroIntervention 2012; 8 (Suppl QI): Q88-93
39. Seiffert M, Bader R, Kappert U, et al. Initial German experience with transapical implantation of a second-generation transcatheter heart valve for the treatment of aortic regurgitation. JACC Cardiovasc Interv 2014; 7I: 1168-74
40. Ensminger S. First results of the JUPITER Registry on long-term performance and safety of the transapical JenaValve. Presented at EuroPCR 2013
41. Kempfert J, Rastan AJ, Beyersdorf F, et al. Trans-apical aortic valve implantation using a new self-expandable bioprosthesis: initial outcomes. Eur J Cardiothorac Surg 2011; 40I: 1114-19
42. Maeda K, Kuratani T, Torikai K, et al. New self-expanding transcatheter aortic valve device for transfemoral implantation- early results of the first-in-asia implantation of the ACURATE Neo/TF(TM) System. Circ J 2015; 79I: 1037-43
43. Holzhey D. Thirty-day outcomes from the multi-center European pivotal trial for transapical transcatheter aortic valve implantation with a self-expanding prosthesis. Engager CE Pivotal Trial data presented at EuroPCR. Paris, France, 2013
44. Willson AB, Rodes-Cabau J, Wood DA, et al. Transcatheter aortic valve replacement with the St. Jude Medical Portico valve: first-in-human experience. J Am Coll Cardiol 2012; 60I: 581-6
45. Abdel-Wahab M, Mehilli J, Frerker C, et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA 2014; 311I; 1503-14
46. Abdel-Wahab M, Zahn R, Horack M, et al. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart 2011; 97I: 899-906
47. Gotzmann M, Pljakic A, Bojara W, et al. Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis-predictors of mortality and poor treatment response. Am Heart J 2011; 162I: 238-45 e1
48. Unbehaun A, Pasic M, Dreysse S, et al. Transapical aortic valve implantation: incidence and predictors of paravalvular leakage and transvalvular regurgitation in a series of 358 patients. J Am Coll Cardiol 2012; 59I: 211-21
49. Berdajs D. Aortic root rupture: implications of catheter-guided aortic valve replacement. Curr Opin Cardiol 2013; 28I: 632-8
50. Facchin M, Mojoli M, Covolo E, et al. The SAPIEN 3 valve: lights and shadows. Minerva med 2014; 105I: 497-500
51. Cao C, Ang SC, Indraratna P, et al. Systematic review and meta-analysis of transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis. Ann Cardiothor Surg 2013; 2I: 10-23
52. Borz B, Durand E, Tron C, et al. Expandable sheath for transfemoral transcatheter aortic valve replacement: procedural outcomes and complications. Catheter Cardiovasc Interv 2014; 83I: E227-32
53. Ludman PF, Moat N, de Belder MA, et al. Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, 2007 to 2012. Circulation 2015; 131I: 1181-90
54. Eggebrecht H, Schmermund A, Voigtlander T, et al. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention 2012; 8I: 129-38
55. Kahlert P, Knipp SC, Schlamann M, et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation 2010; 121I: 870-8
56. Tay EL, Gurvitch R, Wijesinghe N, et al. A high-risk period for cerebrovascular events exists after transcatheter aortic valve implantation. JACC Cardiovasc Interv 2011; 4I: 1290-7
57. Nietlispach F, Wijesinghe N, Gurvitch R, et al. An embolic deflection device for aortic valve interventions. JACC Cardiovasc Interv 2010; 3I: 1133-8
58. Onsea K, Agostoni P, Samim M, et al. First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions. EuroIntervention 2012; 8I: 51-6
59. Rodes-Cabau J, Dauerman HL, Cohen MG, et al. Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events. J Am Coll Cardiol 2013; 62I: 2349-59
60. Orlando R, Pennant M, Rooney S, et al. Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation. Health Technol Assess 2013; 17I: 1-86
61. Roy DA, Schaefer U, Guetta V, et al. Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation. J Am Coll Cardiol 2013; 61I: 1577-84
62. Testa L, Latib A, Rossi ML, et al. CoreValve implantation for severe aortic regurgitation: a multicentre registry. EuroIntervention 2014; 10I: 739-45
63. Mangieri A, Latib A, Aurelio A, et al. Successful implantation of a second-generation aortic valve in severe aortic regurgitation secondary to a traumatic cusp lesion. Cardiovas Revascul Med 2015
64. Tofield A. Feasibility trial reports deployment of new device for TAVI in aortic insufficiency. Eur Heart J 2013; 34I: 2578
65. Bauer T, Linke A, Sievert H, et al. Comparison of the effectiveness of transcatheter aortic valve implantation in patients with stenotic bicuspid versus tricuspid aortic valves (from the German TAVI Registry). Am J Cardiol 2014; 113I: 518-21
66. Yousef A, Simard T, Webb J, et al. Transcatheter aortic valve implantation in patients with bicuspid aortic valve: A patient level multi-center analysis. Int J Cardiol 2015; 189I: 282-8
67. Zegdi R, Blanchard D, Azarine A, et al. Elliptical shape of a SAPIEN XT prosthesis deployed in a patient with bicuspid aortic valve stenosis. J Heart Valve Dis 2012; 21I: 764-6
68. Zhao ZG, Jilaihawi H, Feng Y, et al. Transcatheter aortic valve implantation in bicuspid anatomy. Nature reviews. Cardiology 2015; 12I: 123-8
69. Jamieson WR, Miyagishima RT, Burr LH, et al. Carpentier-Edwards porcine bioprostheses: clinical performance assessed by actual analysis. J Heart Valve Dis 2000; 9I: 530-5
70. Kallikourdis A, Jacob S. Is a stentless aortic valve superior to conventional bioprosthetic valves for aortic valve replacement? Interact Cardiovasc Thorac Surg 2007; 6I; 665-72
71. Webb JG. Transcatheter valve in valve implants for failed prosthetic valves. Catheter Cardiovasc Interv 2007; 70I: 765-6
72. Wenaweser P, Buellesfeld L, Gerckens U, et al. Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: the first valve in valve procedure using the Corevalve Revalving system. Catheter Cardiovasc Interv 2007; 70I: 760-4
73. Dvir D, Webb JG, Bleiziffer S, et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA 2014; 312I: 162-70
74. Lange R, Bleiziffer S, Mazzitelli D, et al. Improvements in transcatheter aortic valve implantation outcomes in lower surgical risk patients: a glimpse into the future. J Am Coll Cardiol 2012; 59I: 280-7
75. Wenaweser P, Stortecky S, Schwander S, et al. Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation. Eur Heart J 2013; 34I: 1894-905
76. Thyregod HG, Steinbruchel DA, Ihlemann N, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-Year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol 2015; 65I: 2184-94
77. Thyregod HG, Sondergaard L, Ihlemann N, et al. The nordic aortic valve intervention (NOTION) trial comparing transcatheter versus surgical valve implantation: study protocol for a randomised controlled trial. Trials 2013; 14I: 11